China Inherited Ventricular Arrhythmias Registry

NCT03880708 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2019-03-26

No results posted yet for this study

Summary

This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.

Conditions

  • Ventricular Arrythmia

Sponsors & Collaborators

  • Renmin Hospital of Wuhan University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Sir Run Run Shaw Hospital

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Beijing Anzhen Hospital

    collaborator OTHER
  • General Hospital of Shenyang Military Region

    collaborator OTHER
  • Xuzhou Central Hospital

    collaborator OTHER
  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER
  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Yan YAO, MD, PhD · China National Center for Cardiovascular Diseases

Eligibility

Min Age
1 Hour
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-24
Primary Completion
2022-10-24
Completion
2027-10-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03880708 on ClinicalTrials.gov